GlassScriptPhysician profile
Niral Patel
NPI 1912923079
$780.93
in general payments reported to CMS, 2019-2025
18 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $202 · 2021: $14.87 · 2022: $73.22 · 2023: $30.99 · 2024: $115 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $164.81 | 2025 | Neurostar Tms Therapy System |
| Biotronik INC. | $146.97 | 2020 | |
| Exact Sciences Corporation | $93.96 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $47.86 | 2020-2022 | |
| Sanofi Pasteur INC. | $43.96 | 2019-2020 | |
| Abbott Laboratories | $39.53 | 2022-2024 | Freestyle Libre |
| Abbvie INC. | $34.99 | 2023-2024 | |
| Novo Nordisk INC | $29.98 | 2019 | |
| Integra Lifesciences Corporation | $23.39 | 2022 | |
| Shire North American Group INC | $22.85 | 2019 | |
| Hologic Sales and Service, LLC | $19.81 | 2024 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $19.33 | 2020 | |
| Alkermes, INC. | $17.67 | 2025 | Aristada, Lybalvi |
| Astrazeneca Pharmaceuticals LP | $16.67 | 2025 | Airsupra |
| Gilead Sciences, INC. | $16.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.81 | 2022 | |
| Phadia US INC. | $13.49 | 2024 | Immunocap |
| Merck Sharp & Dohme LLC | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niral Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.